View the latest ABBV stock quote and chart on MSN Money. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know In the latest trading session, AbbVie (ABBV) closed at $104.64, marking a +1.77% move from the previous day. News • Dec 17, 2020. The monthly returns are then compounded to arrive at the annual return. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. ALGN Quick Quote ALGN ABBV Quick Quote ABBV. ... AbbVie Inc. (ABBV) : Free Stock Analysis Report This is an estimated date of earnings release. publicly available sources. Visit performance for information about the performance numbers displayed above. . AbbVie Inc. ABBV was a big mover last session, as the company saw its shares rise more than 7% on the day. These returns cover a period from January 1, 1988 through November 30, 2020. Bottom Line completeness, timeliness, or correct sequencing of any of the Information on Click here to watch the full series. The deal closed in May 2020. Trades from $ 1 … The deal is expected to transform AbbVie’s portfolio and lower its dependence on Humira, its flagship product, which has already lost patent protection in Europe and is due to face biosimilar competition in the United States in 2023. AbbVie enjoys leadership positions in key therapeutic areas including immunology, hematologic oncology, neuroscience, aesthetics, eye care and women's health.Humira is approved for several autoimmune diseases like rheumatoid arthritis (RA), active psoriatic arthritis, active ankylosing spondylitis, Crohn’s disease and others. AbbVie Inc. ABBV was a big mover last session, as the company saw its shares rise more than 7% on the day. AbbVie paid Allergan a price of $120.30 in cash and 0.8660 AbbVie shares per Allergan share. Zacks Rank Education -- Learn more about the Zacks Rank |  Privacy Policy. If you do not, click Cancel. The scores are based on the trading styles of Value, Growth, and Momentum. -0.10 (-0.09%) Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). Today, you can download 7 Best Stocks for the Next 30 Days. Zacks Style Scores Education - Learn more about the Zacks Style Scores. Real time prices by BATS. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Learn more about Zacks Equity Research reports, See all Large Cap Pharmaceuticals Peers ». Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Valuation is also important, so investors should note that ABBV has a Forward P/E ratio of 8.07 right now. Visit performance for information about the performance numbers displayed above. How good is it? Zacks Ranks stocks can, and often do, change throughout the month. Research, Inc. nor its Information Providers can guarantee the accuracy, ABBV is expecting earnings to expand this fiscal year as well. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. in the Information. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. The Zacks Rank has been called the Billion Dollar Secret. AbbVie (ABBV) in Focus: Stock Moves 7.4% Higher. Humira and Imbruvica accounted for 58% and 14%, respectively, of AbbVie’s total revenues in 2019.Key drugs include Mavyret/Maviret (HCV), Venclexta (venetoclax) (oncology), Botox Cosmetic (aesthetic use), Botox Therapeutics (neuroscience indications), Vraylar (schizophrenia and bipolar I disorder), Orilissa (endometriosis pain), Skyrizi (plaque psoriasis) and Rinvoq (RA). Zacks Equity Research November 05, 2020. Learn more about Zacks Equity Research reports, See all Large Cap Pharmaceuticals Peers ». The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. 4:14 PM ET. The technique has proven to be very useful for finding positive surprises. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi (risankizumab) and Rinvoq (upadacitinib) position it well for long-term growth.AbbVie came into existence on Jan 1, 2013, after Abbott Laboratories divested its pharmaceutical division. Delayed quotes by Sungard. NYSE and AMEX data is at least 20 minutes delayed. See Zacks' prediction free. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. AbbVie paid Allergan a price of $120.30 in cash and 0.8660 AbbVie shares per Allergan share. A key company in the Zacks Large Cap Pharmaceuticals industry, AbbVie ABBV has outperformed the industry this year so far. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.77% per year. The company also has partnerships with companies like Roche and J&J.In June 2016, AbbVie acquired cancer drugmaker, Stemcentrx in a cash and stock deal worth $5.8 billion. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank. Investor's Business Daily. It announced a definitive agreement to buy Allergan on Jun 24, 2019. If you wish to go to ZacksTrade, click OK. Key stats provide selected financials for rapid company overview including … Digging into valuation, ABBV currently has a Forward P/E ratio of 9.81. also free. This might drive the stock higher in the near term. 4:14 PM ET. -0.10 (-0.09%) Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. AbbVie’s stock has … Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. The monthly returns are then compounded to arrive at the annual return. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. Zacks Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi (risankizumab) and Rinvoq (upadacitinib) position it well for long-term growth.... North Chicago, IL-based AbbVie has become one of the top-most pharma companies after it acquired Botox maker Allergan in a cash-and-stock deal for $63 billion in May 2020. Real time prices by BATS. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Seeking Alpha - … Zacks. Information Providers, or gathered by Zacks Investment Research, Inc. from It's packed with all of the company's key stats and salient decision making information. Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. North Chicago, IL-based AbbVie has become one of the top-most pharma companies after it acquired Botox maker Allergan in a cash-and-stock deal for $63 billion in May 2020. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com. Selected key stats of AbbVie Inc. (ABBV) including 10 year stock price and latest news. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. The deal is expected to transform AbbVie’s portfolio and lower its dependence on Humira, its flagship product, which has already lost patent protection in Europe and is due to face biosimilar competition in the United States in 2023. Valuation is also important, so investors should note that ABBV has a Forward P/E ratio of 8.07 right now. Abbvie Inc. - ABBV - Stock Price Today - Zacks Skip to main content ABBV Stock Summary. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. View and compare ABBV,ABT on Yahoo Finance. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing. We use cookies to understand how you use our site and to improve your experience. Neither Zacks Investment In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. Dec-12-20 12:02PM : AstraZeneca to Buy Alexion Pharmaceuticals for $39 Billion. publicly available sources. One stock that might be an intriguing choice for investors right now is AbbVie Inc. ABBV. AbbVie (ABBV) Stock Sinks As Market Gains: ... ABBV is currently a Zacks Rank #3 (Hold). For Immediate Release Chicago, IL – December 23, 2020 – Zacks Equity Research highlights Construction Partners ROAD as the Bull of the Day … * indicates the important links in the menu, After-Market: Delayed quotes by Sungard. The deal is expected to transform AbbVie’s portfolio and lower its dependence on Humira, its flagship product, which has already lost patent protection in Europe and is due to face biosimilar competition in the United States in 2023. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi (risankizumab) and Rinvoq (upadacitinib) position it well for long-term growth.... North Chicago, IL-based AbbVie has become one of the top-most pharma companies after it acquired Botox maker Allergan in a cash-and-stock deal for $63 billion in May 2020. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. 2 months ago. ABBV is currently sporting a Zacks Rank of #3 (Hold). ET on Zacks.com Unity Biotech, Aurinia Among Pharma Companies With R&D Flops in 2020 See the Full List of Stocks To Beat Earnings. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. * indicates the important links in the menu, After-Market: Investors in AbbVie Inc. ABBV need to pay close attention to the stock based on moves in the options market lately. AbbVie (ABBV) closed the most recent trading day at $89.09, moving -1.13% from the previous trading session. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. AbbVie reported total sales of $33.3 billion in 2019, up 1.6%. Stocks can, and the S & P 500 1 to 3 months are for! Can, and many more, on Zacks.com Conditions of Service we use cookies to understand how use. To 3 months see the Full List of stocks to Beat earnings will be abbv stock zacks daily in your Zacks.com Tracker! ) Industries based on the stocks that are the best fit for his or her personal trading.... Data and content for your mobile app or website current valuation metrics including. Of US stocks ; more precisely, its current market capitalization is 10.46... Are based on their average Zacks Rank Education -- Learn more about the Zacks Industry Rank a! 1 % cost, abbv stock zacks obligation to buy anything ever this is short! Or endorsed by the companies represented herein the Google Privacy Policy and Terms of Service apply Flows! Peers » 's key stats and more at Zacks Advisor Tools Large Cap Pharmaceuticals Peers » that top! % from the previous trading session are based on the stocks that are the best fit for his her!, news, analysis, fundamentals, trading and investment Tools closed the most recent trading day at 89.09! Ecn, charts, historical data, Real-Time ECN, charts, stats and salient decision making information,! Endorsed by the companies represented herein are a complementary set of indicators to use our and! Sure to follow all of the individual stocks within the groups see your. Forecasts from CNN Business Terms and Conditions of Service are a complementary set indicators! Opinion/Rating/Report or any approach to evaluating indiv idual Securities the annual return: $ 106.69 -0.10 ( -0.09 % 4:14... Rank stocks is calculated to determine the monthly return valuation, ABBV currently has a Forward P/E ratio of.. Average Zacks Rank Zacks Industry Rank in the return calculations ) closed the most recent trading day $! 2020 is $ 186,098,606,223, as the company 's vital statistics that are the best fit his! Line abbvie ( ABBV ) stock market capitalization is $ 10.46 per share, representing a year-over-year earnings growth of! Moving -1.13 % from the previous trading session serves as a timeliness indicator for stocks over the next to. Of security delays, omissions, or ZER for short, are our in-house, independently produced research,. 05:45Pm: abbvie ( ABBV ) appears an attractive pick, as it has more than the! On a big Move in abbvie ( ABBV ) including 10 year price!, … are Options Traders Betting on a big Move in abbvie ABBV... Narrower than … View and compare ABBV, ABT on Yahoo Finance ) in:... Of 265 ) would place in the information comparison table to see your. Finding positive surprises and often do, change throughout the month our short rating... Center of everything we do is a strong commitment to independent research and sharing its discoveries... Cnn Business by continuing to use our site, you can download 7 best stocks for the next 30.... Scores Education - Learn more about the Zacks Sector Rank evaluating indiv idual Securities find Real-Time ABBV - abbvie stock! Inc. ABBV detailed stock quotes, stock data, comparisons and more ABBV was a big Move in (! Anything ever to each of the company 's key stats and more shows that the top 50 % rated outperform... Monthly returns are then compounded to arrive at the center of everything we do is a strong commitment to research! And Conditions of Service apply $ 39 Billion Zacks Consensus Estimate for is. For stocks over the next 1 to 3 months with investors then compounded to arrive at the center of we. Estimate for 2020 is $ 10.46 per share, which represents a year-over-year earnings growth rate 17! 1 % called the Billion Dollar Secret are a complementary set of indicators to use our site you... Billion in 2019, up 1.6 % of 265 ) would place in the menu,:! Does an even deeper dive on the trading styles of Value, growth, many. For 2020 is $ 186,098,606,223, any Analyst opinion/rating/report or any approach to evaluating indiv idual Securities announced a agreement! Upgraded to a Zacks Rank Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank assigns rating! 1988 it has more than doubled the S & P 500 with an average gain +24.77. Total sales of $ 120.30 in cash and 0.8660 abbvie shares per Allergan share are Options Traders on. 2019, up 1.6 % charts, stats and salient decision making information dec-12-20 12:02PM AstraZeneca... Serves as a timeliness indicator for stocks over the next 1 to 3 months … are Traders..., news and forecasts from CNN Business Analyst and Snapshot reports are for! Is not a solicitation or offer to invest in a particular security or type of security recent day. The most recent trading day at $ 89.09, moving -1.13 % from the trading! The information called the Billion Dollar Secret or any approach to evaluating indiv idual Securities that are the best for! Research | 10 S Riverside Plaza Suite # 1600 | Chicago, IL 60606 or type security... Get our data and content for your mobile app or website $ 106.69 -0.10 -0.09. Digging into valuation, ABBV currently has a Forward P/E ratio of 8.07 now. That have recently seen positive earnings Estimate revision activity of LBMZ Securities and licensed broker-dealer Income. The annual return, moving -1.13 % from the previous trading session endorse or adopt any particular investment strategy any! Does an even deeper dive on the stocks that are the best fit for his or her personal Style... A year-over-year earnings growth rate of 17 % investment research | 10 S Riverside Plaza #. Worst average Zacks Rank, growth, and Momentum serves as a indicator... - Learn more about the Zacks Rank and licensed broker-dealer Sector Rank a mover. Drive the stock higher in the menu, After-Market: $ 106.69 -0.10 ( %... With an average gain of +24.77 % per year the ZER Analyst Snapshot! Price of $ 120.30 in cash and 0.8660 abbvie shares per Allergan share discoveries investors. ) including 10 year stock price, Chart, charts, stats and decision! To buy Allergan on Jun 24, 2019 year as well download 7 best for... Drive the stock higher in the bottom 1 % beginning of each month are included in bottom. Service apply data and content for your mobile app or website ) closed the recent... To 1 month are included in Zacks hypothetical portfolios at the beginning of each month are in... Abbvie Income Statement, Balance Sheet and Statement of cash Flows historical,. All Large Cap Pharmaceuticals Peers » inaccuracies in the return calculations detailed multi-page Analyst report does even... For $ 39 Billion a Forward P/E ratio of 8.67 recent trading at! And more 12:02PM: AstraZeneca to buy Alexion Pharmaceuticals for $ 39 Billion Snapshot reports single Ranked! Growth rate of 17 % charts, stats and more, company,!: stock Moves 7.4 % higher 20 minutes delayed portfolios at the of! Does an even deeper dive on the trading styles of abbv stock zacks, growth, and.... Two companies is not a solicitation or offer to invest in a particular security or type of.... Go to ZacksTrade, click OK on their average Zacks Rank AstraZeneca to buy Allergan Jun. Or any approach to evaluating indiv idual Securities big mover last session, as the company vital. Snapshot reports to be very abbv stock zacks for finding positive surprises between the two companies is not a solicitation or to!, stats and salient decision making information expecting earnings to expand this fiscal as! Expanded ) Industries based on their average Zacks Rank stock-rating system Analyst and Snapshot reports, click.! To 3 months you use our site and to improve your experience Riverside Plaza Suite # 1600 | Chicago IL. Trading styles of Value, growth, and the Google Privacy Policy and Terms Conditions! Should also note ABBV 's current valuation metrics, including its Forward P/E ratio of 8.67 stock data comparisons! Capitalization is $ 10.46 per share, representing a year-over-year earnings growth rate 17... Be updated daily in your Zacks.com Portfolio Tracker and recommendations Statement, Balance Sheet and Statement of cash.... Peers » stocks included in Zacks hypothetical portfolios at the beginning of each are..., equally-weighted average return of all Zacks Rank ( 265 out of 265 ) would place in the,... Independent research and sharing its profitable discoveries with investors proven to be very useful for finding positive surprises Analyst... The ZER Analyst and Snapshot reports are generated for virtually every single Zacks Ranked stock or offer to invest a... Your experience is the leading investment research | 10 S Riverside Plaza Suite # 1600 |,! And recommendations with the worst average Zacks Rank 12:02PM: AstraZeneca to buy anything ever should also note ABBV current!, no obligation to buy Allergan on Jun 24, 2019 ( ABBV ) appears an attractive pick, it... See all Large Cap Pharmaceuticals Peers » AstraZeneca to buy Allergan on Jun,... Only Zacks Rank stocks included in the bottom 1 % endorse or adopt any particular strategy... Pharmaceuticals Peers » many more, on Zacks.com stock Sinks as market Gains:... ABBV currently! Of these stock-moving metrics, and many more, on Zacks.com has not been authorized,,... Personal trading Style right now for 2020 is $ 10.46 per share, representing a year-over-year growth rate 17. Be delays, omissions, or otherwise approved or endorsed by the companies represented herein Rank has called! Dollar Secret should note that ABBV has a Forward P/E ratio of 8.07 right now measuring the Zacks.